Literature DB >> 11815313

Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to complex I deficiency.

Mark J Roef1, Kees de Meer, Dirk-Jan Reijngoud, Helma W H C Straver, Martina de Barse, Satish C Kalhan, Ruud Berger.   

Abstract

BACKGROUND: A high-fat diet has been recommended for the treatment of patients with mitochondrial myopathy due to complex I (NADH dehydrogenase) deficiency (CID).
OBJECTIVE: This study evaluated the effects of intravenous infusion of isoenergetic amounts of triacylglycerol or glucose on substrate oxidation, glycolytic carbohydrate metabolism, and exercise endurance time and energy state of muscle in CID patients.
DESIGN: Four CID patients and 15 control subjects were infused with triacylglycerol (3.7 mg x kg(-1) x min(-1)) or glucose (10 mg x kg(-1) x min(-1)) during low-intensity leg exercise. Respiratory calorimetry was used to evaluate mitochondrial substrate oxidation. The concentration and rate of appearance of plasma lactate (from dilution of [1-(13)C]lactate) were used to evaluate glycolytic carbohydrate metabolism. (31)P magnetic resonance spectroscopy was used to determine ratios of phosphocreatine to inorganic o-phosphate in forearm muscle during exercise.
RESULTS: In 3 patients, leg exercise endurance time was better during the triacylglycerol infusion than during the glucose infusion. In all 4 patients, whole-body oxygen consumption rates during exercise were higher during triacylglycerol infusion than during the glucose infusion. In 3 patients, the concentration and rate of appearance of plasma lactate were lower during triacylglycerol infusion than during the glucose infusion. Ratios of phosphocreatine to inorganic o-phosphate during exercise were not significantly different between the 2 infusion studies or between the patients and control subjects.
CONCLUSIONS: Triacylglycerol infusion is associated with a greater oxidation of substrates, lower rates of appearance and concentrations of plasma lactate, and greater leg exercise endurance time in myopathic CID patients than is glucose infusion. The energy state of muscle during exercise, however, was not significantly different after infusion of triacylglycerol or glucose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815313     DOI: 10.1093/ajcn/75.2.237

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

Review 1.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

Review 2.  Therapies in inborn errors of oxidative metabolism.

Authors:  Manuel Schiff; Paule Bénit; Howard T Jacobs; Jerry Vockley; Pierre Rustin
Journal:  Trends Endocrinol Metab       Date:  2012-05-25       Impact factor: 12.015

3.  Increasing fat in the diet does not improve muscle performance in patients with mitochondrial myopathy due to complex I deficiency.

Authors:  K de Meer; M J Roef; J B C de Klerk; H D Bakker; G P A Smit; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases.

Authors:  J Panetta; L J Smith; A Boneh
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice.

Authors:  Manuel Schiff; Paule Bénit; Riyad El-Khoury; Dimitri Schlemmer; Jean-François Benoist; Pierre Rustin
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

Review 6.  Development of pharmacological strategies for mitochondrial disorders.

Authors:  M Kanabus; S J Heales; S Rahman
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Selection and Characterization of Palmitic Acid Responsive Patients with an OXPHOS Complex I Defect.

Authors:  Tom E J Theunissen; Mike Gerards; Debby M E I Hellebrekers; Florence H van Tienen; Rick Kamps; Suzanne C E H Sallevelt; Elvira N M M-D Hartog; Hans R Scholte; Robert M Verdijk; Kees Schoonderwoerd; Irenaeus F M de Coo; Radek Szklarczyk; Hubert J M Smeets
Journal:  Front Mol Neurosci       Date:  2017-10-18       Impact factor: 5.639

Review 8.  Review: can diet influence the selective advantage of mitochondrial DNA haplotypes?

Authors:  J William O Ballard; Neil A Youngson
Journal:  Biosci Rep       Date:  2015-11-05       Impact factor: 3.840

Review 9.  Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety.

Authors:  Heidi Zweers; Annemiek M J van Wegberg; Mirian C H Janssen; Saskia B Wortmann
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.